Flashman E, Hoffart LM, Hamed RB, Bollinger Jr JM, Krebs C and Schofield CJ (2010). Evidence for the slow reaction of hypoxia-inducible factor prolyl hydroxylase 2 with oxygen. FEBS J. 277: 4089-4099.
Flashman E, Davies SL, Yeoh KK and Schofield CJ (2010). Investigating the dependence of the hypoxia-inducible factor hydroxylases (factor inhibiting HIF and prolyl hydroxylase domain 2) on ascorbate and other reducing agents. Biochem J. 427: 135-142.
Stubbs CJ, Loenarz C, Mecinović J, Yeoh KK, Hindley N, Liénard BM, Sobott F, Schofield CJ and Flashman E (2009). Application of a proteolysis/mass spectrometry method for investigating the effects of inhibitors on hydroxylase structure. J Med Chem. 52: 2799-2805.
Flashman E, Bagg EAL, Chowdhury R, Mecinović J, Loenarz C, McDonough MA, Hewitson KS and Schofield CJ (2008). Kinetic rationale for selectivity towards N- and C-terminal oxygen dependent degradation domain substrates mediated by a loop region of the HIF prolyl hydroxylases. J Biol Chem. 283: 3808-3815.
McDonough MA, Li V, Flashman E, Chowdhury R, Mohr C, Leinard BM, Zondlo J, Oldham NJ, Clifton IJ, Lewis J, McNeill LA, Kurjeza R, Hewitson KS, Yang E, Jordan S, Syed R and Schofield CJ (2006). Cellular oxygen sensing: Crystal structure of hypoxia-inducible factor prolyl hydroxylase (PHD2). Proc. Natl. Acad. Sci. U.S.A. 103: 9814-9819.
McNeill LA, Flashman E, Buck MRG, Hewitson KS, Clifton IJ, Jeschke G, Claridge TDW, Ehrismann D, Oldham NJ and Schofield CJ (2005). Hypoxia-inducible factor prolyl hydroxylase 2 has a high affinity for ferrous iron and 2-oxoglutarate. Mol Biosys. 1: 321-324.